NeuroHealth Expansion?!?!?

Quote
























anonymous said:
Wrong. Its 125 offer with experience. If you negotiate you can get up to 135.
Click to expand...

Ya, but how long will they be around with such a weak product. Uzedy is so late to the game in such a crowded field. I wonder if teva will actually launch the drug or slowly roll it out. I am not sure teva thinks uzedy is a good product. I would not be surprised if teva does a soft launch and drops the NeuroHealth sales division by summer 2024.
 












anonymous said:
Neurohealth will stay. Neuro science will disappear.
Click to expand...

Isn't Neurohealth part of a collaboration like sales division between teva and medincell? I mean everyone has a couple of LAI for schizophrenia. What makes this one better than the other gazillion LAI? How much is uzedy expected to bring in 300-400M? Idk, if you ask me this seems weird. If teva does a soft launch with uzedy, that tells me teva is nervous about the success of this drug. Neuroscience will not disappear. One drug brings in good money and the the other product is a flagship product. Neuroscience is the only division calling on neurologists.
 












anonymous said:
Isn't Neurohealth part of a collaboration like sales division between teva and medincell? I mean everyone has a couple of LAI for schizophrenia. What makes this one better than the other gazillion LAI? How much is uzedy expected to bring in 300-400M? Idk, if you ask me this seems weird. If teva does a soft launch with uzedy, that tells me teva is nervous about the success of this drug. Neuroscience will not disappear. One drug brings in good money and the the other product is a flagship product. Neuroscience is the only division calling on neurologists.
Click to expand...

You people need to understand that Teva is fully aware of what it's doing with this upcoming Uzedy LAI launch. They also already know that the potential sales from Uzedy will be minimal. This recently announced Neuro-Health expansion and overlapping with the current Neuro-Psych Austedo sales force has nothing to do with penetrating an already flooded LAI market with another generic form of Risperidone. This all has to do with Teva's recent partnering and licensing agreement with a company called Medincell and the future uses for their proprietary Steady-Tech injectable delivery device. Teva already has plans in place to put other branded or generic CNS medications into this device to help increase patient compliance and better rates of therapeutic drug levels. Since Teva is still the worlds largest manufacturer of generic medicines, don't think for a minute that other products won't be reformulated and benefit from using this unique delivery device.
 




anonymous said:
You people need to understand that Teva is fully aware of what it's doing with this upcoming Uzedy LAI launch. They also already know that the potential sales from Uzedy will be minimal. This recently announced Neuro-Health expansion and overlapping with the current Neuro-Psych Austedo sales force has nothing to do with penetrating an already flooded LAI market with another generic form of Risperidone. This all has to do with Teva's recent partnering and licensing agreement with a company called Medincell and the future uses for their proprietary Steady-Tech injectable delivery device. Teva already has plans in place to put other branded or generic CNS medications into this device to help increase patient compliance and better rates of therapeutic drug levels. Since Teva is still the worlds largest manufacturer of generic medicines, don't think for a minute that other products won't be reformulated and benefit from using this unique delivery device.
Click to expand...
 




anonymous said:
You people need to understand that Teva is fully aware of what it's doing with this upcoming Uzedy LAI launch. They also already know that the potential sales from Uzedy will be minimal. This recently announced Neuro-Health expansion and overlapping with the current Neuro-Psych Austedo sales force has nothing to do with penetrating an already flooded LAI market with another generic form of Risperidone. This all has to do with Teva's recent partnering and licensing agreement with a company called Medincell and the future uses for their proprietary Steady-Tech injectable delivery device. Teva already has plans in place to put other branded or generic CNS medications into this device to help increase patient compliance and better rates of therapeutic drug levels. Since Teva is still the worlds largest manufacturer of generic medicines, don't think for a minute that other products won't be reformulated and benefit from using this unique delivery device.
Click to expand...
Teva=a pack of muppets
 




anonymous said:
You people need to understand that Teva is fully aware of what it's doing with this upcoming Uzedy LAI launch. They also already know that the potential sales from Uzedy will be minimal. This recently announced Neuro-Health expansion and overlapping with the current Neuro-Psych Austedo sales force has nothing to do with penetrating an already flooded LAI market with another generic form of Risperidone. This all has to do with Teva's recent partnering and licensing agreement with a company called Medincell and the future uses for their proprietary Steady-Tech injectable delivery device. Teva already has plans in place to put other branded or generic CNS medications into this device to help increase patient compliance and better rates of therapeutic drug levels. Since Teva is still the worlds largest manufacturer of generic medicines, don't think for a minute that other products won't be reformulated and benefit from using this unique delivery device.
Click to expand...
Delusional nonsense - Teva doesn’t have the available funds let alone the capability to do this, their focus is biosimilars assuming they haven’t disappeared by the time these come on line.
 




anonymous said:
Delusional nonsense - Teva doesn’t have the available funds let alone the capability to do this, their focus is biosimilars assuming they haven’t disappeared by the time these come on line.
Click to expand...

Delusional? Capability? Go take 10 prescriptions that have a generic equivalent to the pharmacy of your choice and see how quickly your insurance PBM will switch it to a generic to save you money. Then look to see how many of your pill bottles have Teva listed as the manufacturer. Biosimilars are the future for Teva but so is partnering with companies like Medincell that need our manufacturing and technology that is in place. That answers your "capability" remark too when "funding" is provided externally.
 




anonymous said:
Delusional? Capability? Go take 10 prescriptions that have a generic equivalent to the pharmacy of your choice and see how quickly your insurance PBM will switch it to a generic to save you money. Then look to see how many of your pill bottles have Teva listed as the manufacturer. Biosimilars are the future for Teva but so is partnering with companies like Medincell that need our manufacturing and technology that is in place. That answers your "capability" remark too when "funding" is provided externally.
Click to expand...
Teva’s generic sales, margin and share is declining.

Medincell technology would have been assessed by larger more competent companies who were clearly not as easily swayed as Teva. TEVA manufacturing is shambolic … factories in Europe going into hypercare and the methylphenidate debacle are just a couple of examples.

Michael Banks and his team made a shambles of the initial Uzedy submission and TEVA have a current head of R&D who seems to be employed to travel the world taking selfies and talking about COVID.

Keeping drinking the cool aid if it gets you through the day.
 




anonymous said:
Teva’s generic sales, margin and share is declining.

Medincell technology would have been assessed by larger more competent companies who were clearly not as easily swayed as Teva. TEVA manufacturing is shambolic … factories in Europe going into hypercare and the methylphenidate debacle are just a couple of examples.

Michael Banks and his team made a shambles of the initial Uzedy submission and TEVA have a current head of R&D who seems to be employed to travel the world taking selfies and talking about COVID.

Keeping drinking the cool aid if it gets you through the day.
Click to expand...
The only teva is good at is at the glory.hole interfering with goats
 




Teva NeuroHealth sucks! New alignments and weighting blow! Uzedy isn't selling! Dumpster fire manager Bill Henning is living up to his terrible management style reputation from previous companies! Two reps who accepted offers to his region withdrew their offers because they heard about his reputation!
 




Top Bottom
Back
Quote